In the current study, we found that GLUT3, encoded by the SLC2A3 gene, prompted malignant cells to uptake vitamin C. In AML patient blast cells, GLUT3 expression tends to be reduced, which would impede vitamin C uptake and abolish its clinical benefit. This evidence concerns the gene SLC2A3 and acute myeloid leukemia.